Otitis Externa Treatment in Known or Suspected Tympanic Membrane Perforation
Clinical Scenario
Tympanic membrane perforation / Tympanostomy tube
This protocol addresses otitis externa when the tympanic membrane is known or suspected to be nonintact — including patients with a tympanostomy tube. This structural consideration fundamentally changes which topical agents are safe to use and which must be avoided.
Treatment Approach
Management includes pain assessment with analgesic selection guided by severity, alongside a non-ototoxic topical antimicrobial from the only approved class indicated for middle ear use. Certain commonly used topical preparations are contraindicated in this setting. The complete selection criteria, agent options, and ear canal management steps are in the full protocol.
Clinical Goals
- Symptom improvement (otalgia, itching, fullness) within 48–72 hours
- Complete symptom resolution expected within up to 2 weeks
References
DOI: 10.1177/0194599813517083
- When the patient has a known or suspected perforation of the tympanic membrane, including a tympanostomy tube, the clinician should prescribe a non-ototoxic topical preparation.
- The clinician should assess patients with AOE for pain and recommend analgesic treatment based on the severity of pain.
- If the tympanic membrane is known or suspected to be nonintact, topical drops that contain alcohol, have a low pH (most acidifying/antiseptic agents), or both should be avoided because of pain and potential ototoxicity.
- The only topical antimicrobials approved by the FDA (December 2005) for middle ear use are quinolone drops.
- Appropriate treatment of uncomplicated AOE should be followed by symptom improvement (otalgia, itching, fullness) within 48 to 72 hours, although symptom resolution may take up to 2 weeks.
View source ↗